Catalyst Pharmaceuticals autoimmune news

Catalyst reduced headcount by about 30% to conserve cash to complete requirements for an NDA submission for Firdapse

Read the full 185 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE